These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21252750)

  • 41. Abnormal expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in hippocampus, frontal cortex, and substantia nigra of Ts65Dn mouse: a model of Down syndrome.
    Harashima C; Jacobowitz DM; Witta J; Borke RC; Best TK; Siarey RJ; Galdzicki Z
    J Comp Neurol; 2006 Feb; 494(5):815-33. PubMed ID: 16374808
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vasoactive intestinal peptide (VIP) regulates activity-dependent neuroprotective protein (ADNP) expression in vivo.
    Giladi E; Hill JM; Dresner E; Stack CM; Gozes I
    J Mol Neurosci; 2007; 33(3):278-83. PubMed ID: 17952637
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activity-dependent neuroprotective protein-derived peptide, NAP, preventing alcohol-induced apoptosis in fetal brain of C57BL/6 mouse.
    Sari Y
    Neuroscience; 2009 Feb; 158(4):1426-35. PubMed ID: 19073235
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peptide-mediated protection from ethanol-induced neural tube defects.
    Chen SY; Charness ME; Wilkemeyer MF; Sulik KK
    Dev Neurosci; 2005; 27(1):13-9. PubMed ID: 15886480
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome.
    Stagni F; Raspanti A; Giacomini A; Guidi S; Emili M; Ciani E; Giuliani A; Bighinati A; Calzà L; Magistretti J; Bartesaghi R
    Neurobiol Dis; 2017 Jul; 103():11-23. PubMed ID: 28359846
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel VIP responsive gene. Activity dependent neuroprotective protein.
    Gozes I; Zamostiano R; Pinhasov A; Bassan M; Giladi E; Steingart RA; Brenneman DE
    Ann N Y Acad Sci; 2000; 921():115-8. PubMed ID: 11193814
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential effects of ethanol antagonism and neuroprotection in peptide fragment NAPVSIPQ prevention of ethanol-induced developmental toxicity.
    Wilkemeyer MF; Chen SY; Menkari CE; Brenneman DE; Sulik KK; Charness ME
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8543-8. PubMed ID: 12808140
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ethanol antagonist peptides: structural specificity without stereospecificity.
    Wilkemeyer MF; Chen SY; Menkari CE; Sulik KK; Charness ME
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1183-9. PubMed ID: 14762101
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytokine and chemokine alterations in Down syndrome.
    Roberson R; Kuddo T; Horowitz K; Caballero M; Spong CY
    Am J Perinatol; 2012 Oct; 29(9):705-8. PubMed ID: 22644827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ts65Dn mice, a model for Down syndrome, have deficits in context discrimination learning suggesting impaired hippocampal function.
    Hyde LA; Frisone DF; Crnic LS
    Behav Brain Res; 2001 Jan; 118(1):53-60. PubMed ID: 11163633
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The influence of the peptide NAP on Mac-1-deficient mice following closed head injury.
    Zaltzman R; Alexandrovich A; Trembovler V; Shohami E; Gozes I
    Peptides; 2005 Aug; 26(8):1520-7. PubMed ID: 16042992
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice.
    Stagni F; Giacomini A; Guidi S; Ciani E; Ragazzi E; Filonzi M; De Iasio R; Rimondini R; Bartesaghi R
    Neurobiol Dis; 2015 Feb; 74():204-18. PubMed ID: 25497735
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide.
    Bassan M; Zamostiano R; Davidson A; Pinhasov A; Giladi E; Perl O; Bassan H; Blat C; Gibney G; Glazner G; Brenneman DE; Gozes I
    J Neurochem; 1999 Mar; 72(3):1283-93. PubMed ID: 10037502
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulation of Corpus Striatal Neurochemistry by Astrocytes and Vasoactive Intestinal Peptide (VIP) in Parkinsonian Rats.
    Yelkenli İH; Ulupinar E; Korkmaz OT; Şener E; Kuş G; Filiz Z; Tunçel N
    J Mol Neurosci; 2016 Jun; 59(2):280-9. PubMed ID: 27115671
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuroprotective fractalkine in fetal alcohol syndrome.
    Roberson R; Kuddo T; Benassou I; Abebe D; Spong C
    Am J Obstet Gynecol; 2011 May; 204(5):400.e1-3. PubMed ID: 21572545
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuroprotective effect of the peptides ADNF-9 and NAP on hypoxic-ischemic brain injury in neonatal rats.
    Kumral A; Yesilirmak DC; Sonmez U; Baskin H; Tugyan K; Yilmaz O; Genc S; Gokmen N; Genc K; Duman N; Ozkan H
    Brain Res; 2006 Oct; 1115(1):169-78. PubMed ID: 16938277
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel peptides prevent alcohol-induced spatial learning deficits and proinflammatory cytokine release in a mouse model of fetal alcohol syndrome.
    Vink J; Auth J; Abebe DT; Brenneman DE; Spong CY
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):825-9. PubMed ID: 16150281
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Behavioral, cognitive and biochemical responses to different environmental conditions in male Ts65Dn mice, a model of Down syndrome.
    Martínez-Cué C; Rueda N; García E; Davisson MT; Schmidt C; Flórez J
    Behav Brain Res; 2005 Sep; 163(2):174-85. PubMed ID: 15941601
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rescue of synaptic failure and alleviation of learning and memory impairments in a trisomic mouse model of down syndrome.
    Blanchard J; Bolognin S; Chohan MO; Rabe A; Iqbal K; Grundke-Iqbal I
    J Neuropathol Exp Neurol; 2011 Dec; 70(12):1070-9. PubMed ID: 22082658
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The expression of activity-dependent neuroprotective protein (ADNP) is regulated by brain damage and treatment of mice with the ADNP derived peptide, NAP, reduces the severity of traumatic head injury.
    Gozes I; Zaltzman R; Hauser J; Brenneman DE; Shohami E; Hill JM
    Curr Alzheimer Res; 2005 Apr; 2(2):149-53. PubMed ID: 15974912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.